Nanjing Shunxiang Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the R&D, production, sales, and industrial information services of pharmaceutical chemical intermediates. The company operates in collaboration with Nanjing Tengxiang Import & Export Trading Co., Ltd. (established in 2007), leveraging its platform for market promotion and international trade operations. The company's primary product capacities are as follows: Diisopropyl azodicarboxylate (DIAD): Production since 2003, with an annual capacity of 1,500 tons; Diboc (Dibenzoyl-L-tartaric acid): Annual capacity of 5,000 tons; Di-tert-butyl azodicarboxylate (DBAD): Annual capacity of 80 tons; Pyridinium p-toluenesulfonate (PPTS): Annual capacity of 120 tons; Sulfur trioxide pyridine (PST): Annual capacity of 150 tons; Pyridinium tribromide (PHBP): Annual capacity of 90 tons. Looking ahead, Shunxiang Pharmaceutical will continue to deepen its expertise in the pharmaceutical chemical intermediates industry, expand its product portfolio, and strengthen technological innovation. With a global strategic perspective, the company will further enhance cooperation with domestic and international clients while persistently pursuing its long-term vision of becoming "the most enduring specialized chemical manufacturer."

more >
Year of Establishment:
2005
Total Number of Staff:
50-100
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Considerable service and best quality DIBOC Supply.
Patents and Copyrights:
Patent Technology
Research DIBOC production in 2001.
DIBOC technology grow into mature, realize a large-scale production in 2005.
Applized for a patent with the state intellectual property office in 2006.
Won the National Invention Patent of the DIBOC production process in 2009.
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East
Advantage Description: